New Point Of Attack Discovered For Alzheimer's Drug Therapy

Alzheimer's disease is the most common cause of late-life dementia. The disorder is thought to be caused by a protein known as amyloid-beta, or Abeta, which clumps together in the brain, forming plaques that are thought to destroy neurons. This destruction starts early, too, and can presage clinical signs of the disease by up to 20 years. For decades now, researchers have been trying, with limited success, to develop drugs that prevent this clumping. Such drugs require a "target" - a structure they can bind to, thereby preventing the toxic actions of Abeta... via Health News from Medical News Today Read More Here..